8-K - Immunocore Holdings plc | StockGist

Current Report Details

Event Type

Financial Results+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

, and such changes could be material. Additional information and disclosures would also be required for a more complete understanding of the Company’s financial

Financial Results

7.01

of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section

Regulation Fd

8.01

Other Events. On January 9, 2026, the Company published an updated pipeline chart of KIMMRAK (tebentafusp) and its therapeutic candidates in development, which

Other Event

9.01

. Financial Statements and Exhibits Exhibit No. Description 99.1 Press Release dated January 9, 2026. 99.2 Corporate Presentation, dated January 2026. 99.3 Pipe

Exhibits Only

Source Document

Exhibits (4)

8-K

99.1

EXHIBIT 99.1

99.2

EXHIBIT 99.2

99.3

EXHIBIT 99.3